TherapeuticsMD, Inc. (TXMD)
NASDAQ · Healthcare
TherapeuticsMD, Inc. Operating Income 2011–2025
TherapeuticsMD, Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- TherapeuticsMD, Inc. operating income for the quarter ending March 31, 2026 was -723000, a 43.56% decrease year-over-year.
- TherapeuticsMD, Inc. operating income for the twelve months ending March 31, 2026 was -3.6 M, a 47.92% decrease year-over-year.
- TherapeuticsMD, Inc. annual operating income for 2025 was -4.4 M, a 28.17% decrease from 2024.
- TherapeuticsMD, Inc. annual operating income for 2024 was -6.1 M, a 28.29% decrease from 2023.
- TherapeuticsMD, Inc. annual operating income for 2023 was -8.5 M, a 815.62% decrease from 2022.
- TherapeuticsMD, Inc. annual operating income for 2022 was 1.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TherapeuticsMD, Inc. Operating Income — FAQ
TherapeuticsMD, Inc. (TXMD) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is TherapeuticsMD, Inc.'s operating income?
TherapeuticsMD, Inc. (TXMD) reported operating income of -$4M for fiscal 2025.
Where can I see TXMD's operating income history?
The chart and table above show TherapeuticsMD, Inc.'s operating income by year and by quarter, including the growth rate.